SMARCA4 and neoplasm: Whilst Kwon et al. successfully supressed BRG1 activity via the bromodomain, it has been suggested that the ATPase domain may be a better target as catalytic BRG1 ATPase domain activity is essential for SWI/SNF function and tumour cell growth [100].